ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

NCI-Frederick Leases Office Building To Move Some Programs Off Army Base.

February 26, 2010

NCI Grants Payline Could Reach 175 Under Final Fiscal 1985 Awards Level Of Approximately 1,000

August 9, 1985

In Brief: Melanoma Precursors Consensus Conference Planned, DRCC Board Raps Centers Budget Cut

May 20, 1983

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

July 28, 2006

In Brief: FCRF Contract Hopefuls Make Oral Presentation; Jane Rowley To Deliver Karnofsky Lecture

April 10, 1987

Major Emphasis Switch; Outreach Core Support Ends In Favor Of Cancer Control Research

January 22, 1982